share_log

Craig-Hallum Initiates Coverage On Xeris Biopharma Holdings With Buy Rating, Announces Price Target of $4.5

Craig-Hallum Initiates Coverage On Xeris Biopharma Holdings With Buy Rating, Announces Price Target of $4.5

Craig-Hallum以买入评级开始对Xeris Biopharma Holdings进行报道,宣布目标股价为4.5美元
Benzinga ·  2023/08/28 09:32

Craig-Hallum analyst Robin Garner initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy rating and announces Price Target of $4.5.

Craig-Hallum分析师罗宾·加纳以买入评级开始对Xeris Biopharma Holdings(纳斯达克股票代码:XERS)进行报道,并宣布目标股价为4.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发